Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody-drug conjugates
Pharma
Pfizer telegraphs another round of Seagen layoffs
After telegraphing 120 potential Seagen layoffs in March, Pfizer is plowing ahead with efforts to streamline its newly combined cancer business.
Fraiser Kansteiner
May 9, 2024 11:51am
AZ, Daiichi's Enhertu cleared by FDA in wide range of tumors
Apr 8, 2024 10:49am
Daiichi Sankyo spends €1B to bulk up in ADCs
Feb 20, 2024 9:50am
Samsung Biologics, LegoChem link to propel ADC development
Feb 7, 2024 10:16am
Newly spun-off WuXi XDC locks up ADC deal with Korea's Celltrion
Jan 24, 2024 11:04am
Pfizer's $43B buyout of ADC specialist Seagen is a done deal
Dec 14, 2023 10:57am